BIB icon

ProShares Ultra NASDAQ Biotechnology

34 hedge funds and large institutions have $25.3M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.66M
Puts
$5.47M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.34M
2
$3.46M
3
$3.1M
4
$1.88M
5
$1.86M
6
$1.81M
7
$1.15M
8
$777K
9
$518K
10
$405K
11
$344K
12
$306K
13
$259K
14
$237K
15
$221K
16
$142K
17
$129K
18
$103K
19
$43K
20
$36K
21
$24K
22
$23K
23
$22K
24
$22K
25
$17K